Emily Christie

Emily Christie

Auto-generated profile, based on publicly available information

Emily Christie

Division of Nephrology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2023 in American Journal of Transplantation
Verified
Journal Article
Open access
MLMurdoch Leeies
Murdoch Leeies
DCDavid Collister
David Collister
ECEmily Christie
Emily Christie
KDKaren Doucette
Karen Doucette
CHCarmen Hrymak
Carmen Hrymak
JHJulie Ho
Julie Ho
Current policies in organ and tissue donation and transplantation (OTDT) systems in Canada and the United States unnecessarily restrict access to donation for sexual and gender minorities (SGM) and pose safety risks to transplant recipients. We compare SGM-relevant policies between the Canadian and United States systems. Policy domains include the risk assessment of living and deceased organ and tissue donors, physical examination considerations, viral testing recommendations, and informed consent and communication. Identified gaps between current evidence and existing OTDT policies along with differences in SGM-relevant policies between systems, represent an opportunity for improvement. Specific recommendations for OTDT system policy revisions to achieve these goals include the development of behavior-based, gender-neutral risk assessment criteria, a reduction in current SGM no-sexual-contact period requirements pending development of inclusive criteria and de-stigmatization of sexual contact with people living with HIV. OTDT systems should avoid rectal exams to screen for evidence of receptive anal sex without consent and mandate routine NAT screening for all donors. Transplant recipients must receive enhanced risk-to-benefit discussions regarding decisions to accept or decline an offer of an organ classified as increased risk. These recommendations will expand the donor pool, enhance equity for SGM people and improve safety and outcomes for transplant recipients.

1 January 2021 in Canadian Journal of Kidney Health and Disease
Verified
Journal Article
Open access
PDF file
DCDavid Collister
David Collister
NSNathalie Saad
Nathalie Saad
ECEmily Christie
Emily Christie
SASofia Ahmed
Sofia Ahmed

24 September 2024 in American Journal of Transplantation
Verified
Journal Article
Open access
DKDima Kabbani
Dima Kabbani
EOEfrat Orenbuch-Harroch
Efrat Orenbuch-Harroch
Carl BoodmanCarl Boodman
Carl Boodman
SBSarah Broad
Sarah Broad
MPMANUEL PAZ
MANUEL PAZ
KDKaren Doucette
Karen Doucette
Bartonella quintana infection is rarely described to be transmitted through solid organ transplant (SOT). We report a cluster of using donor-derived B quintana infection and the attack rate from Bartonella seropositive donors. In this retrospective study of SOT recipients that received an organ from an unhoused deceased donor (UDD) in Alberta in 2022-2023, serology testing for Bartonella was performed indirect immunofluorescent assay on UDDs and recipients of UDDs with positive serology. Titers ≥1:64 were considered positive. During the study period, 31/32 UDDs were tested for immunoglobulin G to Bartonella (20 negative, 11 positive for B quintana and/or B henselae). Thirty-two organs were transplanted from the 11 seropositive donors. Six SOT recipients developed bartonellosis secondary to B quintana (4 SOT recipients received organs from 3 seropositive donors, and 2 SOT recipients from 1 UDD with no stored sample for testing). The attack rate for clinical disease from positive donors was 12.5% (4/32). The main presentation was skin nodules/papules (median 5.5 months) with bacillary angiomatosis in 4/6. Bartonella serology was positive in 5/6 SOT recipients (initially negative in 2) and blood B quintana quantitative polymerase chain reaction in 1. None had visceral involvement. All donors had history of substance use. This outbreak of bartonellosis reinforces the potential for unexpected donor-transmitted infections. Clinicians should be aware of high transmission of B quintana through transplant from infected UDDs.

12 February 2014 in Seminars in Dialysis
Verified
Journal Article
Closed access
PDF file
ECEmily Christie
Emily Christie
NPNeesh Pannu
Neesh Pannu

10 August 2024 in Current Transplantation Reports
Verified
Journal Article
Closed access
PDF file
ECEmily Christie
Emily Christie
MLMurdoch Leeies
Murdoch Leeies
CWCameron T. Whitley
Cameron T. Whitley
DCDavid Collister
David Collister

1 September 2017 in American Journal of Kidney Diseases
Verified
Journal Article
Closed access
ECEmily Christie
Emily Christie
PCPatricia Campbell
Patricia Campbell
RMRonald Moore
Ronald Moore
DMDermot McNally
Dermot McNally
KWKevin C. Wen
Kevin C. Wen